Skip to content
PICO Portalanswers from OpenAlex

Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy

PaperCitations, authors & open-access status

Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy have?

PICO Portalcitation count

Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy has 205 citations in the OpenAlex counts PICO Portal stores.

When was Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy published?

PICO Portalyear

Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy has 1999 year in the PICO Portal index.

What is the open-access status of Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy?

PICO Portaloa status

Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy has bronze oa status in the PICO Portal index.

What is the DOI of Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy?

PICO Portaldoi

The DOI for Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy is on the source record.

What is the PMID of Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy?

PICO Portalpmid

The PMID for Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy is on the source record.

What is the OpenAlex record for Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy?

PICO Portalopenalex

The OpenAlex for Characterization of neoplastic and normal human breast tissues with in vivo1H MR spectroscopy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial